These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12085968)

  • 41. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch.
    Naumov GN; Akslen LA; Folkman J
    Cell Cycle; 2006 Aug; 5(16):1779-87. PubMed ID: 16931911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Angiogenesis and the regulation of antitumor defense].
    Pappas NP; Hillen HF; Wagstaff J; Griffioen AW
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1555-9. PubMed ID: 10443280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumour angiogenesis.
    Arnold F
    Ann R Coll Surg Engl; 1985 Sep; 67(5):295-8. PubMed ID: 2413796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases.
    Fallah A; Sadeghinia A; Kahroba H; Samadi A; Heidari HR; Bradaran B; Zeinali S; Molavi O
    Biomed Pharmacother; 2019 Feb; 110():775-785. PubMed ID: 30554116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Tumor angiogenesis: new approaches to cancer therapy].
    Marmé D
    Onkologie; 2001 Feb; 24 Suppl 1():1-5. PubMed ID: 11441305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiogenesis-related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinoma.
    Oshima Y; Yajima S; Yamazaki K; Matsushita K; Tagawa M; Shimada H
    Ann Thorac Cardiovasc Surg; 2010 Dec; 16(6):389-93. PubMed ID: 21263418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemokines in tumor-associated angiogenesis.
    Gerber PA; Hippe A; Buhren BA; Müller A; Homey B
    Biol Chem; 2009 Dec; 390(12):1213-23. PubMed ID: 19804363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical procedure as an inducer of tumor angiogenesis.
    Kong B; Michalski CW; Friess H; Kleeff J
    Exp Oncol; 2010 Sep; 32(3):186-9. PubMed ID: 21403615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumour-Endothelial Cell Communications: Important and Indispensable Mediators of Tumour Angiogenesis.
    Lopes-Bastos BM; Jiang WG; Cai J
    Anticancer Res; 2016 Mar; 36(3):1119-26. PubMed ID: 26977007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
    Luttun A; Autiero M; Tjwa M; Carmeliet P
    Biochim Biophys Acta; 2004 Mar; 1654(1):79-94. PubMed ID: 14984769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism and its regulation of tumor-induced angiogenesis.
    Gupta MK; Qin RY
    World J Gastroenterol; 2003 Jun; 9(6):1144-55. PubMed ID: 12800214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editorial: Angiogenesis agents.
    Marcinkiewicz C
    Curr Pharm Des; 2007; 13(35):3543-4. PubMed ID: 18220790
    [No Abstract]   [Full Text] [Related]  

  • 55. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.
    Ranieri G; Gasparini G
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):241-53. PubMed ID: 12477290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiogenesis: molecular mechanisms of activation, promotion and maintenance.
    Bikfalvi A
    J BUON; 2007 Sep; 12 Suppl 1():S59-66. PubMed ID: 17935279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor angiogenesis: biology and therapeutic prospects.
    Harris SR; Thorgeirsson UP
    In Vivo; 1998; 12(6):563-70. PubMed ID: 9891218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer.
    Roškar L; Roškar I; Rižner TL; Smrkolj Š
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin derivatives as angiogenesis inhibitors.
    Presta M; Leali D; Stabile H; Ronca R; Camozzi M; Coco L; Moroni E; Liekens S; Rusnati M
    Curr Pharm Des; 2003; 9(7):553-66. PubMed ID: 12570803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD via downregulating angiogenic factors of endothelial cells.
    Ao Z; Yu S; Qian P; Gao W; Guo R; Dong X; Xu J; Zhang R; Jiang C; Ji F; Qian G
    Biomed Pharmacother; 2017 Mar; 87():539-547. PubMed ID: 28081464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.